Identification of Secondary Metabolites from the Mangrove-Endophyte Lasiodiplodia iranensis F0619 by UPLC-ESI-MS/MS

Lasiodiplodia is a widely distributed fungal genus, frequently found in tropical and subtropical regions where it can cause disease in important crops. It represents a promising source of active secondary metabolites with uses in chemical, pharmaceutical, and agrochemical processes. In this study, t...

Full description

Saved in:
Bibliographic Details
Published in:Metabolites 2023-08, Vol.13 (8), p.912
Main Authors: Delgado Gómez, Lizbeth M., Torres-Mendoza, Daniel, Hernández-Torres, Kathleen, Ortega, Humberto E., Cubilla-Rios, Luis
Format: Article
Language:English
Subjects:
Abscisic acid
Agrochemicals
Chromatography
DNA polymerase
Endophytes
Glycerol
Identification
Ions
jasmonates
Jasmonic acid
Lasiodiplodia
Lasiodiplodia iranensis
mangrove-endophytes
Mass spectrometry
Metabolites
Morphology
MS/MS fragmentation analysis
National parks
Pathogens
Scientific imaging
Secondary metabolites
Threonine
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lasiodiplodia is a widely distributed fungal genus, frequently found in tropical and subtropical regions where it can cause disease in important crops. It represents a promising source of active secondary metabolites with uses in chemical, pharmaceutical, and agrochemical processes. In this study, the strain Lasiodiplodia iranensis F0619 was isolated from the mangrove Avicennia ger-minans, collected from Sarigua National Park in the Republic of Panama. Fractions of crude extract were analyzed by UPLC-ESI-MS/MS, and five compounds, previously reported from Lasiodiplodia genus were identified, including 11,12-didehydro-7-iso-jasmonic acid (1), 4,5-didehydro-7-iso-jasmonic acid (2), cyclo-(L-Leu-L-Pro) (3), jasmonate-threonine (4), and abscisic acid (5). We describe and analyze their MS/MS fragmentation patterns to confirm the compounds ‘chemical structures.
ISSN:2218-1989
2218-1989
DOI:10.3390/metabo13080912